(NASDAQ: IFRX) Inflarx Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 61.8%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.22%.
Inflarx Nv's earnings in 2026 is -$46,631,580.On average, 9 Wall Street analysts forecast IFRX's earnings for 2026 to be -$46,989,409, with the lowest IFRX earnings forecast at -$81,662,391, and the highest IFRX earnings forecast at -$32,010,519. On average, 9 Wall Street analysts forecast IFRX's earnings for 2027 to be -$53,106,975, with the lowest IFRX earnings forecast at -$110,211,031, and the highest IFRX earnings forecast at -$28,453,795.
In 2028, IFRX is forecast to generate -$36,624,098 in earnings, with the lowest earnings forecast at -$42,084,517 and the highest earnings forecast at -$27,911,818.